Oral immunotherapy for peanut allergy

02/5/2014 | Lancet, The

Oral immunotherapy (OIT) successfully induced desensitization in most children in a study population with peanut allergy of any severity, with a clinically meaningful increase in peanut threshold. Quality of life improved after intervention, and there was a good safety profile. Immunological changes corresponded with clinical desensitization. Further studies in wider populations are recommended; peanut OIT should not be done in nonspecialist settings, but it is effective and well tolerated in the studied age group. (Free registration required.)

View Full Article in:

Lancet, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC